| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |